PURPOSE: We measured the perimetric performance in patients with either acquired immunodeficiency syndrome (AIDS) or human immunodeficiency virus (HIV) disease but without AIDS. METHODS: Light-difference sensitivity in the central field was measured in 74 eyes of 37 patients. The Humphrey Field Analyzer 640, program 30-2 was used. Additionally, 143 eyes of 143 normal control subjects were studied. RESULTS: Mean deviation was significantly reduced in patients with HIV disease compared with control subjects (mean +/- S.E.M., -4.30 +/- 0.52 vs -0.77 +/- 0.15, respectively; P < .0001). Analysis of subgroups demonstrated that patients with lymphadenopathy syndrome or AIDS-related complex (N = 40 eyes; -3.52 +/- 0.41; P < .0001) as well as patients with AIDS (N = 34 eyes; -5.23 +/- 0.97; P < .0001) had a reduced mean deviation. Those comparisons remained significant (P < .0001) when data were analyzed independently for the right eyes and for the left eyes. Corrected pattern standard deviation (3.15 +/- 0.30 vs 1.39 +/- 0.09; P < .0001) was higher in patients with HIV disease compared with control subjects. Again, analysis of subgroups disclosed a significant increase in patients with lymphadenopathy syndrome or AIDS-related complex (2.55 +/- 0.36; P < .0001) as well as in patients with AIDS (3.85 +/- 0.51; P < .0001). Both comparisons remained significant when data were analyzed independently for the right and left eyes. CONCLUSIONS: This study demonstrates visual dysfunction despite normal visual acuity in patients with HIV disease. Our results are consistent with the hypothesis of damage at the neuroretinal level.
PURPOSE: We measured the perimetric performance in patients with either acquired immunodeficiency syndrome (AIDS) or human immunodeficiency virus (HIV) disease but without AIDS. METHODS: Light-difference sensitivity in the central field was measured in 74 eyes of 37 patients. The Humphrey Field Analyzer 640, program 30-2 was used. Additionally, 143 eyes of 143 normal control subjects were studied. RESULTS: Mean deviation was significantly reduced in patients with HIV disease compared with control subjects (mean +/- S.E.M., -4.30 +/- 0.52 vs -0.77 +/- 0.15, respectively; P < .0001). Analysis of subgroups demonstrated that patients with lymphadenopathy syndrome or AIDS-related complex (N = 40 eyes; -3.52 +/- 0.41; P < .0001) as well as patients with AIDS (N = 34 eyes; -5.23 +/- 0.97; P < .0001) had a reduced mean deviation. Those comparisons remained significant (P < .0001) when data were analyzed independently for the right eyes and for the left eyes. Corrected pattern standard deviation (3.15 +/- 0.30 vs 1.39 +/- 0.09; P < .0001) was higher in patients with HIV disease compared with control subjects. Again, analysis of subgroups disclosed a significant increase in patients with lymphadenopathy syndrome or AIDS-related complex (2.55 +/- 0.36; P < .0001) as well as in patients with AIDS (3.85 +/- 0.51; P < .0001). Both comparisons remained significant when data were analyzed independently for the right and left eyes. CONCLUSIONS: This study demonstrates visual dysfunction despite normal visual acuity in patients with HIV disease. Our results are consistent with the hypothesis of damage at the neuroretinal level.
Authors: Partho S Kalyani; Gary N Holland; Amani A Fawzi; Tiago E F Arantes; Fei Yu; Alfredo A Sadun Journal: Am J Ophthalmol Date: 2012-01-15 Impact factor: 5.258
Authors: Sarah Cheng; Helaina Klein; Dirk-Uwe Bartsch; Igor Kozak; Thomas D Marcotte; William R Freeman Journal: Graefes Arch Clin Exp Ophthalmol Date: 2011-07-06 Impact factor: 3.117
Authors: Iryna A Falkenstein; Dirk-Uwe Bartsch; Stanley P Azen; Laurie Dustin; Alfredo A Sadun; William R Freeman Journal: Am J Ophthalmol Date: 2008-02-15 Impact factor: 5.258
Authors: Michael H Goldbaum; Irina Falkenstein; Igor Kozak; Jiucang Hao; Dirk-Uwe Bartsch; Terrance Sejnowski; William R Freeman Journal: Trans Am Ophthalmol Soc Date: 2008
Authors: William R Freeman; J Allen McCutchan; J Fernando Arevalo; Tanya Wolfson; Thomas D Marcotte; Robert K Heaton; Igor Grant Journal: Ocul Immunol Inflamm Date: 2004-03 Impact factor: 3.070
Authors: Igor Kozak; Pamela A Sample; Jiucang Hao; William R Freeman; Robert N Weinreb; Te-Won Lee; Michael H Goldbaum Journal: Trans Am Ophthalmol Soc Date: 2007
Authors: William R Freeman; Mark L Van Natta; Douglas Jabs; Pamela A Sample; Alfredo A Sadun; Jennifer Thorne; Kayur H Shah; Gary N Holland Journal: Am J Ophthalmol Date: 2008-01-11 Impact factor: 5.258
Authors: Michael H Goldbaum; Igor Kozak; Jiucang Hao; Pamela A Sample; TeWon Lee; Igor Grant; William R Freeman Journal: Graefes Arch Clin Exp Ophthalmol Date: 2010-09-24 Impact factor: 3.117